Educational strategies to achieve professional excellence

Saturday 3 October 2015
D2*     Session accredited under ACPE, UAN: 0579-0000-15-014-L04-P (3.0 contact hours)

Organised by the FIP Programme Committee


Professional excellence requires pharmacists to take responsibility and accountability for patients’ health outcomes. To achieve this level of professional excellence, pharmacists must exhibit the attributes of a patient-centred practitioner.  Fundamental to these attributes are the abilities to provide competent, compassionate and ethical care for patients that include the ability to interpret and apply scientific evidence to individual patients, generate evidence when it does not exist or needs improvement, fully engage in team-based patient care and maintain expertise through advanced training or professional development. The education of students and training of practitioners lays key foundations for achieving professional excellence that meets societal needs.

Learning objectives

Application-based session

At the conclusion of this session, participants will be able to:

  1. Adopt educational methods that develop a scientific approach to practice.
  2. Analyse educational approaches to prepare students to practise in a team-based care model.
  3. Endorse programmes that advance professional excellence among practitioners.
  4. Compare different models of learning providing the right context for students and practitioners.

Chairs: Ralph Altiere (University of Colorado, USA) and Linda Aagaard Thomsen (Pharmakon, Denmark)


09:00 1) Introduction by the Chair

09:05 2) Educating scientific thinkers – using and creating evidence to inform patient care
Rebekah Moles (The University of Sydney, Australia)

09:35 3) Healthcare team education – inter-professional education
Roderick Salenga (UP College of Public Health, Philippines)

10:05 Break

10:20 4) Advancing practitioners’ professional excellence
Ryan Jacobsen (University of Iowa Health Care, USA)

10:50 5) How to provide practice context in the academic environment?
Martine Ruggli, Pharmasuisse (Switzerland)

11:20 6) Roundtable discussions, reports and panel Q & A